PRESS RELEASE published on 02/19/2026 at 07:17, 2 months 18 days ago BioVersys and partners’ phase 2a tuberculosis trial results published in New England Journal of Medicine BioVersys and partners demonstrate promising results with AlpE in Phase 2a tuberculosis trial, published in New England Journal of Medicine. AlpE shows potential in treating drug-resistant tuberculosis Clinical Trial Drug Resistance BioVersys Tuberculosis AlpE
PRESS RELEASE published on 02/19/2026 at 07:01, 2 months 18 days ago Knorr-Bremse on course for success with higher profit and profitability Knorr-Bremse reports higher profit and profitability in 2025, achieving €1 billion operating EBIT and expanding EBIT margin to 13%. Strong Q4 results with 6.4% organic revenue growth Revenue Growth EBIT Knorr-Bremse Profit BOOST Strategy
PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Cembra reports further net income increase by 5% driven by disciplined strategy execution Cembra Money Bank AG reports 5% net income increase to CHF180 million in 2025. Strong financial performance driven by disciplined strategy execution and cost savings Financial Performance Cost Savings Cembra Money Bank AG Net Income Increase Strategy Execution
PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Notice of ABB’s Annual General Meeting on March 19, 2026 ABB announces Annual General Meeting on March 19, 2026, in Zurich, Switzerland. Details on agenda, registration, proxy/voting, and elections included Annual General Meeting Switzerland AGM ABB Zurich
PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Notice of ABB’s Annual General Meeting on March 19, 2026 ABB to hold Annual General Meeting on March 19, 2026 in Zurich, Switzerland. Shareholders can participate in person or by proxy. Agenda includes director elections and compensation approvals Annual General Meeting Shareholders Compensation ABB Zurich
REGULATED PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months
REGULATED PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months
PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago TBSO confirme son éligibilité aux dispositifs PEA et PEA-PME TBSO confirme son éligibilité aux dispositifs PEA et PEA-PME selon les critères du Code monétaire et financier. Les actions TBSO (FR0000063307) peuvent être intégrées aux comptes PEA-PME PEA-PME PEA Fiscalité Éligibilité TBSO
REGULATED PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Gimv builds on strong growth to deliver solid results Record investment level in a shortened financial year of 9 months
REGULATED PRESS RELEASE published on 02/19/2026 at 07:00, 2 months 18 days ago Gimv zet sterk groeitraject voort met solide resultaten Recordinvesteringen in boekjaar van 9 maanden
Published on 05/09/2026 at 01:30, 22 hours 20 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 23 hours 50 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 4 hours 45 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 3 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 4 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 4 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 4 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 4 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 4 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 4 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 4 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
